Literature DB >> 15225331

A political history of medicare and prescription drug coverage.

Thomas R Oliver1, Philip R Lee, Helene L Lipton.   

Abstract

This article examines the history of efforts to add prescription drug coverage to the Medicare program. It identifies several important patterns in policymaking over four decades. First, prescription drug coverage has usually been tied to the fate of broader proposals for Medicare reform. Second, action has been hampered by divided government, federal budget deficits, and ideological conflict between those seeking to expand the traditional Medicare program and those preferring a greater role for private health care companies. Third, the provisions of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 reflect earlier missed opportunities. Policymakers concluded from past episodes that participation in the new program should be voluntary, with Medicare beneficiaries and taxpayers sharing the costs. They ignored lessons from past episodes, however, about the need to match expanded benefits with adequate mechanisms for cost containment. Based on several new circumstances in 2003, the article demonstrates why there was a historic opportunity to add a Medicare prescription drug benefit and identify challenges to implementing an effective policy.

Mesh:

Year:  2004        PMID: 15225331      PMCID: PMC2690175          DOI: 10.1111/j.0887-378X.2004.00311.x

Source DB:  PubMed          Journal:  Milbank Q        ISSN: 0887-378X            Impact factor:   4.911


  20 in total

1.  A drug benefit: the necessary prescription for Medicare.

Authors:  J Rother
Journal:  Health Aff (Millwood)       Date:  1999 Jul-Aug       Impact factor: 6.301

2.  Covering prescription drugs under Medicare: for the good of the patients.

Authors:  A F Holmer
Journal:  Health Aff (Millwood)       Date:  1999 Jul-Aug       Impact factor: 6.301

3.  Trends in Medicare supplemental insurance and prescription drug coverage, 1996-1999.

Authors:  Mary A Laschober; Michelle Kitchman; Patricia Neuman; Allison A Strabic
Journal:  Health Aff (Millwood)       Date:  2002 Jul-Dec       Impact factor: 6.301

4.  The pursuit of biohappiness.

Authors:  Leon R Kass
Journal:  Washington Post       Date:  2003-10-16

5.  Managing the pharmacy benefit in Medicare HMOs: what do we really know?

Authors:  H L Lipton; D J Gross; M R Stebbins; L H Syed
Journal:  Health Aff (Millwood)       Date:  2000 Mar-Apr       Impact factor: 6.301

6.  Panel of scientists supports review of biomedical research that terrorists could use.

Authors:  Nicholas Wade
Journal:  N Y Times Web       Date:  2003-10-09

7.  Employer-sponsored health insurance and prescription drug coverage for new retirees: dramatic declines in five years.

Authors:  Bruce Stuart; Puneet K Singhal; Cheryl Fahlman; Jalpa Doshi; Becky Briesacher
Journal:  Health Aff (Millwood)       Date:  2003 Jul-Dec       Impact factor: 6.301

8.  Analysis, advice, and congressional leadership: the Physician Payment Review Commission and the politics of Medicare.

Authors:  T R Oliver
Journal:  J Health Polit Policy Law       Date:  1993       Impact factor: 2.265

9.  Tracking health care costs: trends slow in first half of 2003.

Authors:  Bradley C Strunk; Paul B Ginsburg
Journal:  Data Bull (Cent Stud Health Syst Change)       Date:  2003-12

10.  National health expenditures, 1998.

Authors:  C A Cowan; H C Lazenby; A B Martin; P A McDonnell; A L Sensenig; J M Stiller; L S Whittle; K A Kotova; M A Zezza; C S Donham; A M Long; M W Stewart
Journal:  Health Care Financ Rev       Date:  1999
View more
  12 in total

Review 1.  Pharmacy utilization and the Medicare Modernization Act.

Authors:  Vittorio Maio; Laura Pizzi; Adam R Roumm; Janice Clarke; Neil I Goldfarb; David B Nash; David Chess
Journal:  Milbank Q       Date:  2005       Impact factor: 4.911

2.  Public/private partnerships for prescription drug coverage: policy formulation and outcomes in Quebec's universal drug insurance program, with comparisons to the Medicare prescription drug program in the United States.

Authors:  Marie-Pascale Pomey; Pierre-Gerlier Forest; Howard A Palley; Elisabeth Martin
Journal:  Milbank Q       Date:  2007-09       Impact factor: 4.911

Review 3.  The patient protection and Affordable Care Act: a primer for hand surgeons.

Authors:  Joshua M Adkinson; Kevin C Chung
Journal:  Hand Clin       Date:  2014-08       Impact factor: 1.907

Review 4.  Medicare Part D's Effects on Drug Utilization and Out-of-Pocket Costs: A Systematic Review.

Authors:  Young Joo Park; Erika G Martin
Journal:  Health Serv Res       Date:  2016-08-01       Impact factor: 3.402

5.  Impact of Medicare Part D on Racial and Ethnic Minorities.

Authors:  JoEllen Jarrett Jamison; Junling Wang; Satya Surbhi; Samantha Adams; David Solomon; Kenneth C Hohmeier; Sharon McDonough; James C Eoff
Journal:  Divers Equal Health Care       Date:  2016-08-23

6.  Who Pays in Medicare Part D? Giving Plans More Skin in the Game.

Authors:  Erin E Trish; Paul B Ginsburg; Geoffrey F Joyce; Dana P Goldman
Journal:  N Engl J Med       Date:  2019-11-20       Impact factor: 91.245

7.  Subsidy Design in Privately Provided Social Insurance: Lessons from Medicare Part D.

Authors:  Francesco Decarolis; Maria Polyakova; Stephen P Ryan
Journal:  J Polit Econ       Date:  2020-03-18

8.  Market Size and Innovation: Effects of Medicare Part D on Pharmaceutical Research and Development.

Authors:  Margaret E Blume-Kohout; Neeraj Sood
Journal:  J Public Econ       Date:  2013-01

9.  Utilization of elective hip and knee arthroplasty by age and payer.

Authors:  Dan Matlock; Mark Earnest; Anne Epstein
Journal:  Clin Orthop Relat Res       Date:  2008-01-23       Impact factor: 4.176

10.  Healthcare reform in the United States and China: pharmaceutical market implications.

Authors:  Arthur Daemmrich; Ansuman Mohanty
Journal:  J Pharm Policy Pract       Date:  2014-07-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.